Precision Biosciences Inc
DTIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357874
In the last 90 days, Precision Biosciences Inc insiders filed 3 open-market purchases and 1 sale; 96 institutions reported holding it in 13F filings for Q2 2026, worth $139.5M in total; no superinvestor holds it.
Holders of 5% or more of DTIL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Precision Biosciences Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Readout Capital, LP | 13G/A | 9.40%1.12M shares | +0.50 ppfrom 8.90% | Mar 26, 20252 filings | Aug 14, 2025 | SEC |
| Standard Life Aberdeen plc | 13G | 8.88%2.14M shares | New | Jan 27, 20261 filing | Jan 27, 2026 | SEC |
| Bleichroeder LP | 13G/A | 8.21%1.90M shares | −1.48 ppfrom 9.69% | Aug 14, 20252 filings | Feb 13, 2026 | SEC |
| Octagon Capital Advisors LP | 13G/A | 5.73%1.65M shares | −4.26 ppfrom 9.99% | Feb 10, 20262 filings | Nov 3, 2026 | SEC |
| Lynx1 Capital Management LP | 13G | 5.40%1.39M shares | +1.30 ppfrom 4.10% | Feb 14, 20254 filings | Jul 20, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.01%1.38M shares | New | Oct 27, 20261 filing | Oct 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
52 Schedule 13D and 13G filings on Precision Biosciences Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 20264:02 PM ET | Octagon Capital Advisors LPand 2 others | 13G/A | 5.73%1.65M shares | −4.26 ppfrom 9.99% | Sep 30, 2026 | SEC |
| Oct 27, 20265:25 PM ET | BlackRock, Inc. | 13G | 5.01%1.38M shares | New | Sep 30, 2026 | SEC |
| Aug 24, 20263:13 PM ET | Weinstein Benjamin | 13G/A | 4.00%1.11M shares | −1.20 ppfrom 5.20%Below 5% | Aug 21, 2026 | SEC |
| Jul 29, 20264:15 PM ET | Empery Asset Management, LPand 1 other | 13G/A | 4.99%1.31M shares | −2.64 ppfrom 7.63%Below 5% | Jun 30, 2026 | SEC |
| Jul 20, 20264:10 PM ET | Lynx1 Capital Management LPand 1 other | 13G | 5.40%1.39M shares | +1.30 ppfrom 4.10% | Jul 13, 2026 | SEC |
| Apr 15, 20269:46 AM ET | Empery Asset Management, LPand 1 other | 13G/A | 7.63%1.97M shares | −2.36 ppfrom 9.99% | Mar 31, 2026 | SEC |
| Feb 17, 20264:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 0.00%0 shares | −6.40 ppfrom 6.40%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20261:46 PM ET | Lynx1 Capital Management LPand 1 other | 13G/A | 4.10%993.9K shares | −4.70 ppfrom 8.80%Below 5% | Dec 31, 2025 | SEC |
| Feb 13, 20264:44 PM ET | Bleichroeder LPand 2 others | 13G/A | 8.21%1.90M shares | −1.48 ppfrom 9.69% | Dec 31, 2025 | SEC |
| Feb 10, 20261:15 PM ET | Octagon Capital Advisors LPand 2 others | 13G | 9.99%2.33M shares | New | Dec 31, 2025 | SEC |
| Jan 27, 202610:10 AM ET | Standard Life Aberdeen plcand 1 other | 13G | 8.88%2.14M shares | New | Dec 31, 2025 | SEC |
| Jan 22, 20261:01 PM ET | Empery Asset Management, LPand 1 other | 13G | 9.99%2.30M shares | New | Dec 31, 2025 | SEC |
| Nov 14, 20252:02 PM ET | Lynx1 Capital Management LPand 1 other | 13G/A | 8.80%1.04M shares | −1.19 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Aug 14, 20254:09 PM ET | Readout Capital, LPand 4 others | 13G/A | 9.40%1.12M shares | +0.50 ppfrom 8.90% | Jun 30, 2025 | SEC |
| Aug 14, 202511:14 AM ET | Bleichroeder LPand 2 others | 13G | 9.69%1.07M shares | New | Jun 30, 2025 | SEC |
| Aug 6, 20254:48 PM ET | Aquilo Capital Management, LLCand 2 others | 13G/A | 0.00%0 shares | −9.90 ppfrom 9.90%Below 5% | Jun 30, 2025 | SEC |
| Aug 6, 20254:01 PM ET | Novartis Pharma AGand 1 other | 13G/A | 3.70%413.6K shares | −1.70 ppfrom 5.40%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 6.40%673.3K shares | – | Mar 31, 2025 | SEC |
| Apr 25, 20252:16 PM ET | Highbridge Capital Management LLC | 13G/A | 3.70%406.3K shares | –Below 5% | Mar 31, 2025 | SEC |
| Mar 26, 20256:09 PM ET | Readout Capital, LPand 4 others | 13G | 8.90%932.9K shares | New | Mar 19, 2025 | SEC |
| Mar 18, 20255:13 PM ET | Weinstein Benjamin | 13G | 5.20%395.5K shares | New | Mar 18, 2025 | SEC |
| Feb 14, 202511:59 AM ET | Aquilo Capital Management, LLCand 2 others | 13G/A | 9.90%791.9K shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202511:35 AM ET | Janus Henderson Group PLC | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20259:01 AM ET | Lynx1 Capital Management LPand 1 other | 13G | 9.99%766.1K shares | New | Dec 31, 2024 | SEC |
| Feb 12, 20255:00 PM ET | Novartis Pharma AGand 1 other | 13G/A | 5.40%413.6K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Tang Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Highbridge Capital Management LLC | 13GOld format | – | New | – | SEC |
| Mar 18, 2024 | Aquilo Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Mar 14, 2024 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Mar 11, 2024 | Janus Henderson Group PLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Great Point Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2024 | Tang Capital Partners LP | 13GOld format | – | New | – | SEC |
| Feb 27, 2023 | Great Point Partners LLC | 13GOld format | – | – | – | SEC |
| Feb 14, 2023 | Great Point Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 27, 20234:57 PM ET | Eli Lilly & Co | 13G/AOld format | – | – | – | SEC |
| Aug 31, 2022 | Jantz Derek | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jul 1, 2022 | Great Point Partners LLC | 13GOld format | – | New | – | SEC |
| Jun 27, 2022 | Novartis Pharma AG | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Jantz Derek | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 2, 20227:11 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
41 notices from officers, directors and other affiliates planning to sell Precision Biosciences Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 202610:50 AM ET | Scimeca DarioOfficer | 2.82K | $27.5K | Nov 10, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Nov 6, 20264:30 PM ET | Smith J. JeffersonOfficer | 875 | $8.96K | Nov 6, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Nov 5, 20264:15 PM ET | Smith J. JeffersonOfficer | 7.06K | $72.4K | Nov 5, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Feb 18, 20265:05 PM ET | Smith J. JeffersonOfficer | 4.92K | $18.9K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| Feb 18, 20264:31 PM ET | Scimeca DarioOfficer | 4.92K | $18.9K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| Feb 18, 20264:30 PM ET | Amoroso MichaelOfficer · Director | 20.6K | $79.0K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| Feb 18, 20264:19 PM ET | Kelly John AlexanderOfficer | 8.15K | $31.3K | Feb 18, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jan 22, 20263:19 PM ET | Amoroso MichaelOfficer · Director | 34.8K | $145.2K | Jan 22, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jan 21, 20264:19 PM ET | Scimeca DarioOfficer | 8.85K | $35.7K | Jan 21, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jan 21, 20264:14 PM ET | Smith J. JeffersonOfficer | 10.2K | $41.1K | Jan 21, 2026 | Fidelity Brokerage Services LLC | SEC |
| Jan 21, 20264:07 PM ET | Kelly John AlexanderOfficer | 15.2K | $61.3K | Jan 21, 2026 | Fidelity Brokerage Services LLC | SEC |
| Nov 3, 20253:16 PM ET | Kelly John AlexanderOfficer | 1.30K | $8.46K | Nov 3, 2025 | Fidelity Brokerage Services LLC | SEC |
| Nov 3, 20253:15 PM ET | Amoroso MichaelOfficer · Director | 3.41K | $22.1K | Nov 3, 2025 | Fidelity Brokerage Services LLC | SEC |
| Nov 3, 20253:07 PM ET | Scimeca DarioOfficer | 665 | $4.32K | Nov 3, 2025 | Fidelity Brokerage Services LLC | SEC |
| Jul 3, 20253:25 PM ET | Kelly John AlexanderOfficer | 14.8K | $63.2K | Jul 3, 2025 | Fidelity Brokerage Services LLC | SEC |
| Mar 24, 20253:13 PM ET | Amoroso MichaelOfficer · Director | 964 | $5.36K | Mar 24, 2025 | Fidelity Brokerage Services LLC | SEC |
| Mar 5, 20253:17 PM ET | List AlanOfficer | 333 | $1.68K | Mar 5, 2025 | Fidelity Brokerage Services LLC | SEC |
| Mar 4, 20254:15 PM ET | Smith J. JeffersonOfficer | 154 | $756.16 | Mar 4, 2025 | Fidelity Brokerage Services LLC | SEC |
| Mar 4, 20254:13 PM ET | Scimeca DarioOfficer | 272 | $1.34K | Mar 4, 2025 | Fidelity Brokerage Services LLC | SEC |
| Jan 24, 20253:10 PM ET | List AlanOfficer | 672 | $3.39K | Jan 24, 2025 | Fidelity Brokerage Services LLC | SEC |
| Jan 22, 20253:14 PM ET | Scimeca DarioOfficer | 8.93K | $42.7K | Jan 22, 2025 | Fidelity Brokerage Services LLC | SEC |
| Jan 22, 20253:13 PM ET | Smith J. JeffersonOfficer | 10.3K | $49.2K | Jan 22, 2025 | Fidelity Brokerage Services LLC | SEC |
| Jan 21, 20254:19 PM ET | Amoroso MichaelOfficer · Director | 36.8K | $172.2K | Jan 21, 2025 | Fidelity Brokerage Services LLC | SEC |
| Nov 4, 20243:51 PM ET | Scimeca DarioOfficer | 588 | $4.82K | Nov 4, 2024 | Fidelity Brokerage Services LLC | SEC |
| Nov 4, 20243:49 PM ET | Amoroso MichaelOfficer · Director | 3.01K | $24.7K | Nov 4, 2024 | Fidelity Brokerage Services LLC | SEC |
Showing the latest 25. See the DTIL notices from the last 12 months